Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation
Liang Shan,Ning Zhao,Fengling Wang,Dandan Zhai,Jianjun Liu,Xiongwen Lv
DOI: https://doi.org/10.2147/jir.s424384
IF: 4.5
2024-03-11
Journal of Inflammation Research
Abstract:Liang Shan, 1– 4, &ast Ning Zhao, 2– 4, &ast Fengling Wang, 1 Dandan Zhai, 1 Jianjun Liu, 1 Xiongwen Lv 2– 4 1 Department of Pharmacy, the Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui, 230011, People's Republic of China; 2 Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, 230032, People's Republic of China; 3 Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, 230032, People's Republic of China; 4 The Key Laboratory of Major Autoimmune Diseases, Hefei, Anhui Province, 230032, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianjun Liu, Department of Pharmacy, the Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui, 230011, People's Republic of China, Tel +86 551 62965335, Fax +86 551 62965335, Email Xiongwen Lv, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, 230032, People's Republic of China, Tel +86 55165161000, Fax +86 551 65161000, Email The use of caffeine in treating various liver diseases has made substantial progress in the past decade owing to advances in science, technology, and medicine. However, whether caffeine has a preventive effect on hepatocellular carcinoma (HCC) and its mechanism are still worth further investigation. In this review, we summarize and analyze the efficacy and safety of caffeine in the prevention of HCC. We conducted a review of articles published in PubMed and Web of Science in the past 2 decades until December 6, 2023, which were searched for using the terms "Caffeine" and "Hepatocellular Carcinoma." Studies have found that coffee intake is negatively correlated with HCC risk, especially caffeinated coffee. Recent studies have found that caffeine has beneficial effects on liver health, decreasing levels of enzymes responsible for liver damaging and slowing the progression of hepatic fibrosis and cirrhosis. Caffeine also acts against liver fibrosis through adenosine receptors (ARs), which promote tissue remodeling by inducing fibrin and collagen production. Additionally, new studies have found that moderate consumption of caffeinated beverages can decrease various the levels of various collagens in patients with chronic hepatitis C. Furthermore, polyphenolic compounds in coffee can improve fat homeostasis, reduce oxidative stress, and prevent liver steatosis and fibrosis. Moreover, many in vitro studies have shown that caffeine can protect liver cells and inhibit the activation and proliferation of hepatic stellate cells. Taken together, we describe the benefits of caffeine for liver health and highlight its potential values as a drug to prevent various hepatic diseases. As a protective agent of liver inflammation, non-selective AR inhibitor caffeine can inhibit the growth of HCC cells by inhibiting adenosine and AR binding to initiate immune response, providing a basis for the future development of caffeine as an adjuvant drug against HCC. Keywords: coffee, caffeine, hepatocellular carcinoma, adenosine, adenosine receptor Caffeine, with the chemical formula C 8 H 10 N 4 O 2 , is a bitter white crystal belonging to the xanthine alkaloid compound family. Thus, it is chemically similar to the adenine and guanine present in deoxyribonucleic acid (DNA). 1 Consuming caffeinated beverages can relieve or prevent drowsiness and increase energy. The part of the coffee plant that contains caffeine is extracted to make beverages. 2 These drinks are popular in North America, where 90% of adults consume caffeine every day. Caffeine is a central nervous stimulant that temporarily dispels drowsiness and restores energy. Additionally, caffeine is the most widely used legal and unregulated psychoactive drug in the world because it is widely used clinically in coma resuscitation, as well as in caffeinated coffee, tea, soft drinks, and energy drinks. 3 Most prominently, caffeine is a nonselective adenosine receptor (AR) antagonist that reversibly blocks the action of adenosine on the receptor, thereby blocking adenosine and AR binding-induced sleepiness in the central nervous system. Recently, emerging data suggest that coffee consumption is inversely associated with the progression of liver fibrosis to cirrhosis and even hepatocellular carcinoma (HCC), although there is no evidence of a causal relationship. 1,4 In the last decade, studies have found that caffeine has pharmacological effects, including against Alzheimer's disease, in which it excites the cardiovascular system and cerebrovascular system, -Abstract Truncated-
immunology